XML 25 R7.htm IDEA: XBRL DOCUMENT v3.24.3
CONSOLIDATED STATEMENTS OF MEZZANINE EQUITY AND STOCKHOLDERS’ DEFICIT - USD ($)
$ in Thousands
Total
Sonder Legacy Warrants
Delayed Draw Warrants
As Previously Reported
Retroactive adjustment to reflect the exchange ratio due to business combination
Redeemable Convertible Preferred Stock
Redeemable Convertible Preferred Stock
As Previously Reported
Redeemable Convertible Preferred Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
Exchangeable Preferred Stock
Exchangeable Preferred Stock
As Previously Reported
Exchangeable Preferred Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
Post-Combination Exchangeable Common Stock
Common Stock
Common Stock
Common Stock
Common Stock
Sonder Legacy Warrants
Common Stock
Common Stock
As Previously Reported
[1]
Common Stock
Common Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
[1]
Common Stock
Exchangeable Series AA Stock
Common Stock
Exchangeable Series AA Stock
As Previously Reported
Common Stock
Exchangeable Series AA Stock
Retroactive adjustment to reflect the exchange ratio due to business combination
[1]
Common Stock
Post-Combination Exchangeable Common Stock
Common Stock
Post-Combination Exchangeable Common Stock
As Previously Reported
Additional Paid-in Capital
[1]
Additional Paid-in Capital
Sonder Legacy Warrants
[1]
Additional Paid-in Capital
Delayed Draw Warrants
[1]
Additional Paid-in Capital
As Previously Reported
[1]
Accumulated Translation Adjustment
Accumulated Translation Adjustment
As Previously Reported
Accumulated Deficit
Accumulated Deficit
As Previously Reported
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2020 [1]           5,556,051 3,783,233 1,772,818 925,669 630,308 295,361                                    
Mezzanine equity, beginning balance at Dec. 31, 2020           $ 517,730 [1] $ 517,730 [1]   $ 49,733 $ 49,733                                      
Increase (Decrease) in Mezzanine Equity                                                          
Issuance of Series E Convertible Preferred Stock (in shares) [1]           6,819                                              
Issuance of Series E Convertible Preferred Stock [1]           $ 1,020                                              
Exchange of Exchangeable Preferred Stock to Convertible Preferred Stock (in shares) [1]           699     (699)                                        
Mezzanine equity, ending balance (As Restated) (in shares) at Dec. 31, 2021 [1]           5,563,569     924,970                                        
Mezzanine equity, ending balance at Dec. 31, 2021           $ 518,750 [1]     $ 49,733                                        
Beginning balance (As Restated) (in shares) at Dec. 31, 2020                         526,474 [1]   358,487 167,987 692,984 [1] 471,868 [1] 221,116 0 0                
Beginning balance (As Restated) at Dec. 31, 2020 $ (504,962)     $ (500,860) $ (4,102)               $ 0 [1]   $ 0   $ 0 $ 0   $ 0 $ 0 $ 13,899     $ 13,899 $ 5,666 $ 5,666 $ (524,527) $ (524,527)
Increase (Decrease) in Stockholders' Deficit                                                          
Exchange of Series AA stock to common stock (in shares) [1]                         1,187       (1,187)                        
Exercise of common stock options (in shares) [1]                         105,830                                
Exercise of common stock options 3,841                                         3,841              
Exercise of common stock warrants (in shares) [1]                         4,117                                
Exercise of common stock warrants 120                                         120              
Stock-based compensation 25,247                                         25,247              
Components of comprehensive loss:                                                          
Net loss (293,955)     (294,387) 432                                             (293,955)  
Change in cumulative translation adjustment 1,633                                                 1,633      
Ending balance (As Restated) (in shares) at Dec. 31, 2021                         637,608 [1]       691,797 [1]     0                  
Ending balance (As Restated) at Dec. 31, 2021 (768,076)     (764,406) (3,670)               $ 0 [1]       $ 0     $ 0   43,107       7,299   (818,482)  
Components of comprehensive loss:                                                          
Net loss 13,147     10,963 2,184                                                
Ending balance (As Restated) at Mar. 31, 2022 133,517     135,988 (2,471)                                                
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021 [1]           5,563,569     924,970                                        
Mezzanine equity, beginning balance at Dec. 31, 2021           $ 518,750 [1]     $ 49,733                                        
Beginning balance (As Restated) (in shares) at Dec. 31, 2021                         637,608 [1]       691,797 [1]     0                  
Beginning balance (As Restated) at Dec. 31, 2021 (768,076)     (764,406) (3,670)               $ 0 [1]       $ 0     $ 0   43,107       7,299   (818,482)  
Components of comprehensive loss:                                                          
Net loss (41,497)     (34,703) (6,794)                                                
Ending balance (As Restated) at Jun. 30, 2022 89,162     101,092 (11,930)                                                
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021 [1]           5,563,569     924,970                                        
Mezzanine equity, beginning balance at Dec. 31, 2021           $ 518,750 [1]     $ 49,733                                        
Beginning balance (As Restated) (in shares) at Dec. 31, 2021                         637,608 [1]       691,797 [1]     0                  
Beginning balance (As Restated) at Dec. 31, 2021 (768,076)     (764,406) (3,670)               $ 0 [1]       $ 0     $ 0   43,107       7,299   (818,482)  
Components of comprehensive loss:                                                          
Net loss (114,618)     (108,392) (6,226)                                                
Ending balance (As Restated) at Sep. 30, 2022 26,635     38,771 (12,136)                                                
Mezzanine equity, beginning balance (in shares) at Dec. 31, 2021 [1]           5,563,569     924,970                                        
Mezzanine equity, beginning balance at Dec. 31, 2021           $ 518,750 [1]     $ 49,733                                        
Increase (Decrease) in Mezzanine Equity                                                          
Conversion of preferred stock (in shares) [1]           (5,563,569)                                              
Conversion of preferred stock [1]           $ (518,750)                                              
Conversion of exchangeable stock in connection with the business combination (in shares) [1]                 (924,970)                                        
Conversion of exchangeable stock in connection with the business combination                 $ (49,733)                                        
Beginning balance (As Restated) (in shares) at Dec. 31, 2021                         637,608 [1]       691,797 [1]     0                  
Beginning balance (As Restated) at Dec. 31, 2021 (768,076)     (764,406) (3,670)               $ 0 [1]       $ 0     $ 0   43,107       7,299   (818,482)  
Increase (Decrease) in Stockholders' Deficit                                                          
Conversion of Sonder Legacy Warrants from liabilities to equity 2,111                                         2,111              
CEO promissory note settlement (in shares) [1]                         (136,281)                                
Conversion of Sonder Legacy Warrants (in shares) [1]                           7,761                              
Conversion of Sonder Legacy Warrants   $ 1,243                                         $ 1,243            
Conversion of convertible note (in shares) [1]                         950,855                                
Conversion of convertible note 159,173                                         159,173              
Conversion of preferred stock (in shares) [1]                         5,563,569                                
Conversion of preferred stock $ 518,761                       $ 1 [1]                 518,760              
Exercise of common stock options (in shares) 46,568                       46,568 [1]                                
Exercise of common stock options $ 1,620                                         1,620              
Issuance of common stock in connection with the business combination and PIPE offering (in shares) [1]                         2,192,291                                
Issuance of common stock in connection with the business combination and PIPE offering 267,362                                         267,362              
Assumption of SPAC Warrants upon consummation of business combination (25,985)                                         (25,985)              
Earn Out Liability recognized upon consummation of business combination (98,117)                                         (98,117)              
Issuance of Delayed Draw Warrants     $ 5,598                                         $ 5,598          
Conversion of exchangeable stock in connection with the business combination (in shares)                                 (691,797) [1]     1,616,767                  
Conversion of exchangeable stock in connection with the business combination 49,733                                         49,733              
Vesting of restricted stock units (in shares) [1]                         60,038                                
Vesting of restricted stock units 58                                         58              
Conversion of exchangeable stock (in shares)                         597,307 [1]             (597,307)                  
Conversion of exchangeable stock 1                                         1              
Stock-based compensation 24,337                                         24,337              
Components of comprehensive loss:                                                          
Net loss (245,031)     (165,742) (79,289)                                             (245,031)  
Change in cumulative translation adjustment 5,727                                                 5,727      
Ending balance (As Restated) (in shares) at Dec. 31, 2022                       1,019,460 9,919,716 [1]       0 [1]     1,019,460                  
Ending balance (As Restated) at Dec. 31, 2022 (101,485)     (19,947) (81,538)               $ 1 [1]       $ 0     $ 0   949,001       13,026   (1,063,513)  
Beginning balance (As Restated) at Mar. 31, 2022 133,517     135,988 (2,471)                                                
Components of comprehensive loss:                                                          
Net loss (54,644)     (45,666) (8,978)                                                
Ending balance (As Restated) at Jun. 30, 2022 89,162     101,092 (11,930)                                                
Components of comprehensive loss:                                                          
Net loss (73,121)     (73,689) 568                                                
Ending balance (As Restated) at Sep. 30, 2022 26,635     38,771 (12,136)                                                
Beginning balance (As Restated) at Dec. 31, 2022 (101,485)     (19,947) (81,538)               $ 1 [1]       $ 0     $ 0   949,001       13,026   (1,063,513)  
Components of comprehensive loss:                                                          
Net loss (81,865)     (86,431) 4,566                                                
Ending balance (As Restated) at Mar. 31, 2023 (175,955)     (96,827) (79,128)                                                
Beginning balance (As Restated) (in shares) at Dec. 31, 2022                       1,019,460 9,919,716 [1]       0 [1]     1,019,460                  
Beginning balance (As Restated) at Dec. 31, 2022 (101,485)     (19,947) (81,538)               $ 1 [1]       $ 0     $ 0   949,001       13,026   (1,063,513)  
Components of comprehensive loss:                                                          
Net loss (126,049)     (131,758) 5,709                                                
Ending balance (As Restated) at Jun. 30, 2023 (215,262)     (136,592) (78,670)                                                
Beginning balance (As Restated) (in shares) at Dec. 31, 2022                       1,019,460 9,919,716 [1]       0 [1]     1,019,460                  
Beginning balance (As Restated) at Dec. 31, 2022 (101,485)     (19,947) (81,538)               $ 1 [1]       $ 0     $ 0   949,001       13,026   (1,063,513)  
Components of comprehensive loss:                                                          
Net loss (183,679)     (196,034) 12,355                                                
Ending balance (As Restated) at Sep. 30, 2023 (264,421)     (192,688) (71,733)                                                
Beginning balance (As Restated) (in shares) at Dec. 31, 2022                       1,019,460 9,919,716 [1]       0 [1]     1,019,460                  
Beginning balance (As Restated) at Dec. 31, 2022 $ (101,485)     (19,947) (81,538)               $ 1 [1]       $ 0     $ 0   949,001       13,026   (1,063,513)  
Increase (Decrease) in Stockholders' Deficit                                                          
Exercise of common stock options (in shares) 469                       469 [1]                                
Exercise of common stock options $ 8                                         8              
Vesting of restricted stock units (in shares) [1]                         154,062                                
Conversion of exchangeable stock (in shares)                         306,478 [1]             (306,478)                  
Stock-based compensation 28,494                                         28,494              
Components of comprehensive loss:                                                          
Net loss (295,668)                                                     (295,668)  
Change in cumulative translation adjustment (8,050)                                                 (8,050)      
Ending balance (As Restated) (in shares) at Dec. 31, 2023                       712,982 10,380,725 [1]       0 [1]     712,982                  
Ending balance (As Restated) at Dec. 31, 2023 (376,701)                       $ 1 [1]       $ 0     $ 0   $ 977,503       $ 4,976   $ (1,359,181)  
Beginning balance (As Restated) at Mar. 31, 2023 (175,955)     (96,827) (79,128)                                                
Components of comprehensive loss:                                                          
Net loss (44,184)     (45,327) 1,143                                                
Ending balance (As Restated) at Jun. 30, 2023 (215,262)     (136,592) (78,670)                                                
Components of comprehensive loss:                                                          
Net loss (57,630)     (64,276) 6,646                                                
Ending balance (As Restated) at Sep. 30, 2023 $ (264,421)     $ (192,688) $ (71,733)                                                
[1] Prior period balances have been adjusted to reflect the Reverse Stock Split at a ratio of 1-for-20 that became effective on September 20, 2023. See Note 1, Basis of Presentation, for additional information regarding the Reverse Stock Split.